Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma.

Trial Profile

Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2011

At a glance

  • Drugs Carboplatin (Primary) ; Thalidomide (Primary)
  • Indications Glioma
  • Focus Therapeutic Use
  • Most Recent Events

    • 24 Jun 2011 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
    • 22 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 29 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top